Lexette® Foam (halobetasol propionate) | Official Patient Website
Extractables and Leachables: Quality Concerns and Considerations for Ophthalmic and Injectable Products | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Apellis' eye med application on track for next year after FDA OKs inclusion of phase 2 data | Fierce Pharma